Lv2
180 积分 2024-01-05 加入
New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer
3天前
已完结
Advances in Ovarian Cancer Care and Unmet Treatment Needs for Patients With Platinum Resistance: A Narrative Review
4天前
已完结
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
17天前
已完结
Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer
17天前
已完结
2022: Perioperative and critical care year in review for the cardiothoracic surgery team
18天前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
25天前
已完结
Decreased blood glucose at admission has a prognostic impact in patients with severely decompensated acute heart failure complicated with diabetes mellitus
30天前
已完结
Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design
1个月前
已完结
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
1个月前
已完结
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
